Advertisement

GI & Endoscopy

Advertisement

The FDA has released the first official, legally binding rules regulating what food companies can label as gluten-free, according to a capital public radio report.

Takeda Pharmaceutical Company has submitted a biologics license application to the FDA for its Crohn's disease and ulcerative colitis treatment vedolizumab, according to a Gastroenterology & Endoscopy News report.

Advertisement